Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Recall of Rho(D) Immune Globulin (Human); Hyper RHO S/D, Mini-Dose-Talecris Biotherapeutics, Inc


April 18, 2008


Rho(D) Immune Globulin (Human); HyperRHO S/D, Mini-Dose

Lot Number: 26N7XX1
Expiration: June 29, 2009
NDC Number: 13533-631-06


Talecris Biotherapeutics, Inc.
Clayton, North Carolina


This lot of HyperRHO S/D, Mini-Dose is currently testing less than the full potency of 250 IU/dose as labeled. The potency, as currently tested, is 204 IU/dose. This lot was at the full potency of 250 IU/dose through December 2007, the 18 month stability test point. Customers are asked to immediately examine their stock to determine if they have any of the above mentioned lot and return product to Talecris Biotherapeutics, Inc.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 06/27/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English